دورية أكاديمية

Targeting nf-κb by the cell-permeable nemo-binding domain peptide improves albuminuria and renal lesions in an experimental model of type 2 diabetic nephropathy

التفاصيل البيبلوغرافية
العنوان: Targeting nf-κb by the cell-permeable nemo-binding domain peptide improves albuminuria and renal lesions in an experimental model of type 2 diabetic nephropathy
المؤلفون: Opazo-Ríos, Lucas, Plaza, Anita, Matus, Yenniffer Sánchez, Bernal, Susana, Lopez-Sanz, Laura, Jimenez-Castilla, Luna, Carpio, Daniel, Droguett, Alejandra, Mezzano, Sergio, Egido, Jesús, Gómez Guerrero, Carmen
المساهمون: UAM. Departamento de Medicina, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)
بيانات النشر: MDPI, Basel, SMwitzerland
سنة النشر: 2021
المجموعة: Universidad Autónoma de Madrid (UAM): Biblos-e Archivo
مصطلحات موضوعية: Albuminuria, BTBR ob/ob mice, Diabetic nephropathy, Inflammation, NF-κB pathway, Medicina
الوصف: Diabetic nephropathy (DN) is a multifactorial disease characterized by hyperglycemia and close interaction of hemodynamic, metabolic and inflammatory factors. Nuclear factor-κB (NF-κB) is a principal matchmaker linking hyperglycemia and inflammation. The present work investigates the cell-permeable peptide containing the inhibitor of kappa B kinase γ (IKKγ)/NF-κB essential modulator (NEMO)-binding domain (NBD) as therapeutic option to modulate inflammation in a preclinical model of type 2 diabetes (T2D) with DN. Black and tan, brachyuric obese/obese mice were randomized into 4 interventions groups: Active NBD peptide (10 and 6 µg/g body weight); Inactive mutant peptide (10 µg/g); and vehicle control. In vivo/ex vivo fluorescence imaging revealed efficient delivery of NBD peptide, systemic biodistribution and selective renal metabolization. In vivo administration of active NBD peptide improved albuminuria (>40% reduction on average) and kidney damage, decreased podocyte loss and basement membrane thickness, and modulated the expression of proinflammatory and oxidative stress markers. In vitro, NBD blocked IKK-mediated NF-κB induction and target gene expression in mesangial cells exposed to diabetic-like milieu. These results constitute the first nephroprotective effect of NBD peptide in a T2D mouse model that recapitulates the kidney lesions observed in DN patients. Targeting IKK-dependent NF-κB activation could be a therapeutic strategy to combat kidney inflammation in DN. ; This work was supported by grants from: Fondecyt Project No 1160465 to S.M. and PhD CONICYT Grant No 21150768 to L.O-R.; Spanish Ministry of Economy and Competitiveness (MINECO/FEDER; SAF2015-63696-R to C.G-G.), Ministry of Science and Innovation (MICINN/FEDER; RTI2018-098788-B-1I00 to C.G-G.) and Instituto de Salud Carlos III (FIS/FEDER; PI17/01495 and DTS-2017/00203 to J.E.)
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 1661-6596
العلاقة: International Journal of Molecular Sciences; http://doi.org/10.3390/ijms21124225Test; Gobierno de España. PI17/01495; Gobierno de España. DTS-2017/00203; International Journal of Molecular Sciences 21.12 (2020): 4225; http://hdl.handle.net/10486/695184Test; 4225-1; 12; 4225-17; 21
DOI: 10.3390/ijms21124225
الإتاحة: https://doi.org/10.3390/ijms21124225Test
http://hdl.handle.net/10486/695184Test
حقوق: © 2020 The Authors ; Reconocimiento ; openAccess
رقم الانضمام: edsbas.23988A89
قاعدة البيانات: BASE
الوصف
تدمد:16616596
DOI:10.3390/ijms21124225